Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study

被引:6
|
作者
Huang, Guang-Ming [1 ]
Qiu, Yue [1 ]
Liu, Tao-Tao [1 ]
Lu, Jie-Jiu [1 ]
机构
[1] Guangxi Med Univ, Dept Pharm, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 62卷 / 07期
基金
中国国家自然科学基金;
关键词
augmented renal clearance; critically ill infant; normal renal function; population pharmacokinetics; vancomycin; STAPHYLOCOCCUS-AUREUS INFECTIONS; PEDIATRIC-PATIENTS; TROUGH CONCENTRATIONS; FEBRILE NEUTROPENIA; CYTOKINES; EXPOSURE; CHILDREN; OUTCOMES;
D O I
10.1002/jcph.2029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Augmented renal clearance presents as super-renal function with enhanced renal perfusion and glomerular hyperfiltration in many critically ill infants. This study was to compare vancomycin clearance (CL) between critically ill infants with augmented renal clearance and with normal renal function and to optimize the vancomycin dosage. Data were retrospectively obtained from infants treated in intensive care units. Population pharmacokinetics analysis was conducted using nonlinear mixed-effects model software. A total of 66 critically ill infants were included: 47 infants with augmented renal clearance and 19 infants with normal renal function. The median doses of vancomycin for infants with augmented renal clearance and with normal renal function were 48 and 47 mg/kg/day (P > .05), respectively. The median CL in infants with augmented renal clearance was increased 1.96-fold compared with infants who had normal renal function (0.98 versus 0.5 L/h, P < .001). Simulations indicated that the recommended dosage of 60, 70, 80, 90, and 100 mg/kg/day would be appropriate in critically ill infants with an estimated glomerular filtration rate (eGFR) of 130-149, 150-169, 170-189, 190-209, and >210 mL/min/1.73 m(2), respectively. Doses of 70 and 75 mg/kg/day were recommended for infants with augmented renal clearance and gestational ages of 27-32.9 and 33-39 weeks, respectively. Doses of 70, 75, 80, and 90 mg/kg/day were recommended for infants with augmented renal clearance and weights of 2.0-2.9, 3.0-3.9, 4.0-4.9, and 5.0-6.0 kg, respectively. In conclusion, the typical vancomycin dosage is insufficient for critically ill infants with augmented renal clearance. Premature infants and infants of low weight with augmented renal clearance need individualized dosing regimens to obtain an adequate area under the serum concentration time curve over 24 h/minimum inhibitory concentration ratio.
引用
下载
收藏
页码:863 / 872
页数:10
相关论文
共 50 条
  • [1] Piperacillin population pharmacokinetics and optimization in critically ill children with normal and augmented renal clearance
    Beranger, A.
    Benaboud, S.
    Urien, S.
    Moulin, F.
    Bille, E.
    Lesage, F.
    Zheng, Y.
    Genuini, M.
    Gana, I.
    Renolleau, S.
    Hirt, D.
    Treluyer, J. M.
    Oualha, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 21 - 21
  • [2] The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients
    Tesfamariam, Novel Solomon
    Aboelezz, Asma
    Mahmoud, Sherif Hanafy
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [3] Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance
    Agathe Béranger
    Sihem Benaboud
    Saïk Urien
    Florence Moulin
    Emmanuelle Bille
    Fabrice Lesage
    Yi Zheng
    Mathieu Genuini
    Inès Gana
    Sylvain Renolleau
    Déborah Hirt
    Jean-Marc Tréluyer
    Mehdi Oualha
    Clinical Pharmacokinetics, 2019, 58 : 223 - 233
  • [4] IMPACT OF AUGMENTED RENAL CLEARANCE ON VANCOMYCIN IN CRITICALLY ILL TRAUMA PATIENTS
    Rice, Timothy
    Droege, Molly
    Philpott, Carolyn
    Courter, Joshua
    Desai, Pankaj
    Harger, Nicole
    Ernst, Neil
    Foertsch, Madeline
    Healy, Daniel
    Karve, Aniruddha
    Liao, Siyun
    Mueller, Eric
    Winter, Jessica
    Goodman, Michael
    Droege, Chris
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 642 - 642
  • [5] Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
    Chu, Yang
    Luo, Yifan
    Ji, Shuangmin
    Jiang, Mingyan
    Zhou, Baosen
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (01) : 68 - 74
  • [6] Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance
    He, Cui-Yao
    Ye, Pan-Pan
    Liu, Bin
    Song, Lin
    van den Anker, John
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [7] A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
    He, Juan
    Yang, Zhi-Tao
    Qian, Xian
    Zhao, Bing
    Mao, En-Qiang
    Chen, Er-Zhen
    Bian, Xiao-Lan
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2166 - 2171
  • [8] THE IMPACT OF AUGMENTED RENAL CLEARANCE ON VANCOMYCIN THERAPY IN CRITICALLY ILL TRAUMA PATIENTS
    Rice, Timothy
    Droege, Christopher
    Droege, Molly
    Mueller, Eric
    Ernst, Neil
    Liao, Siyun
    Goodman, Michael
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 779 - 779
  • [9] RISK FACTORS OF AUGMENTED RENAL CLEARANCE IN CRITICALLY ILL CHILDREN USING IOHEXOL CLEARANCE FOR RENAL FUNCTION ASSESSMENT
    Thatparan, Tharshiya
    Marro, Julien
    Hawcutt, Daniel
    ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (06) : A10 - A10
  • [10] Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance
    Fratoni, Andrew J.
    Mah, John W.
    Nicolau, David P.
    Kuti, Joseph L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (11) : 2992 - 2999